KdT Ventures
KdT Ventures is a venture capital firm specializing in early-stage frontier science investing. They focus on companies re-architecting the world at a molecular level, particularly in chemistry and biology. Their unique model allows for significant impact in the earliest stages of a venture.
📥 Buy Full VC Dataset
Offices: San Francisco (United States), Austin (United States), Durham (United States), Chicago (United States)
Investment Stages: Seed, Series A
Markets: Biotechnology, Therapeutics, Genomics, AI, Medical Technology, Agriculture, Materials Science
Founded Year: 2017
Investor Type: Venture Capital
Portfolio Companies: PathAI, Tavros Therapeutics, Remedy Robotics, Elegen, Checkerspot, STRM.BIO, Solugen, Terray Therapeutics, Dyno Therapeutics, Debut Biotechnology, 54Gene, Abridge, Azitra, Elemental Machines, Hi Fidelity Genetics, Patch'd, Rejuvenate Bio, Theator, Tierra Biosciences, Braid Health, Andes, Circularis, Xilis, Revel, Dimension Inx, Onc.AI, Faeth, SeQure, Marigold Health, Parthenon, Modulus, Zymochem, Molecule, Cypris Materials, Canaery, Tacit Therapeutics, Equii, Character, Elo Life Systems, Nosis Bio, Aperiam Bio, Perceptive, Syenex, March Bio
Website: https://www.kdtvc.com
Team Page: https://www.kdtvc.com/#our-team
Portfolio Link: https://www.kdtvc.com/portfolio/
LinkedIn: https://www.linkedin.com/company/kdt-ventures
Crunchbase: https://www.crunchbase.com/organization/kdt-ventures
Pitchbook: https://pitchbook.com/profiles/investor/186571-63
Comments
No comments yet. Be the first to comment!